| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, and
Pulmonary and Critical Care Medicine Section, Medical Service, Department of Veterans Affairs Medical Center, Ann Arbor, MI 48105
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
and decreased IL-4, IL-13, and IL-5). Similar types of
changes were seen in whole-lung protein concentrations for TNF-
,
IL-10, IL-12 p40, IFN-, and IL-4. Additionally, mRNA expression of
the endothelial selectins CD62E and CD62P decreased and lung lymphocyte
apoptosis increased in the 3IT group. Thus, physiologic down-regulation
of the pulmonary immune response to repeated Ag exposure is
characterized by increased anti- and decreased proinflammatory
cytokines that accompanies Th1 polarization. Similar mechanisms may act
to minimize chronic lung inflammation in the majority of normal humans
who do not develop progressive lung pathology when repeatedly exposed
to inhaled or aspirated environmental Ags. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
To this purpose, we and others have analyzed the response of Ag-primed animals of a variety of species to intratracheal (IT)4 challenge with the prototypic particulate T cell Ag, the SRBC (1). The most prevalent model system uses inbred mice, predominantly of the C57BL/6 or A/J strains, which are high responders to SRBC (2, 3, 4). This experimental model system has been used to analyze the anatomic and molecular mechanisms of lymphocyte recruitment to lung parenchyma (5, 6, 7), the cytokine requirements for airways hyperresponsiveness (AHR) (8), and the role of neuropeptides in development of lung inflammation (9). Lung inflammation in this model system depends crucially on recruitment of functional CD4+ cells, which enter the lung via both VLA-4-dependent and selectin-dependent pathways (10, 11). Net lung lymphocyte accumulation depends minimally on in situ lymphocyte proliferation, but is associated with prominent lung eosinophilia (12). We have observed previously that inflammatory cell recruitment is accompanied by transient angiitis, alveolar macrophage activation, and in situ maturation of specific Ab-secreting cells; however fibrosis is not seen (5, 13). Thus, this experimental model system shares many of the characteristics of relevant human immunologic lung diseases. Importantly, however, the response is self-limiting within 3 wk (3, 5).
A key question in pulmonary immunology is why a minority of individuals develop progressive lung inflammation to ubiquitous inhaled agents that are ignored by the immune systems of most exposed individuals. One potential clue to this puzzle comes from animal models that indicate that the pulmonary immune response typically decreases spontaneously during repeated pulmonary Ag challenge of normal animals (14, 15, 16, 17). Thus, normal animals appear to mimic the natural response of most healthy humans to inhalation of noninjurious Ags. The molecular basis for this waning response during continued Ag exposure remains unknown despite considerable study. Evidence against a variety of mechanisms has been provided. The normally antiproliferative effect of alveolar macrophages on activated lymphocytes in vitro is not decreased on repeated challenge of rabbits or mice with Micropolyspora faeni (18, 19). Peripheral lymphocyte tolerance does not occur using multiple IT challenges of M. faeni in rabbits or Thermoactinomyces vulgaris Ag in mice (20, 21), and T suppresser activity is not enhanced on repeated challenge of mice with T. vulgaris Ag (21). However, because T cells can differentiate in vivo into immune or suppressor cells depending upon the nature and dosage of Ag (22, 23, 24), oral tolerance cannot be totally eliminated as an explanation for the waning response to multiple challenge.
We have previously found that termination of the pulmonary immune response to a single IT SRBC challenge does not require CD8+ T cells, but does involve considerable lymphocyte apoptosis within the alveolar space and lung interstitium (13, 25). We also found that, at the single time-point tested, the magnitude of lung inflammation and lymphocyte accumulation after three IT Ag challenges is markedly less than after a single IT Ag challenge (25). Previous experiments showed that multiple i.p. priming exposures to SRBC did not appreciably alter lung lymphocyte numbers after single IT challenge (12), excluding the trivial explanation of exhaustion of the systemic immune response or systemic tolerance. These findings suggested that a variation of our well-characterized model system could be studied to understand the mechanism of this previously described physiologic down-regulation seen in many animal models of pulmonary hypersensitivity. The goal of this study was to further characterize the down-regulation of lung inflammation and of lymphocyte accumulation on repeated IT Ag challenge, which we hypothesized would result from decreased production of proinflammatory cytokines within the lungs. We found that repeated Ag challenge was associated with up-regulation of antiinflammatory IL-10 as well as a down-regulation of E- and P-selectin mRNA. These changes were accompanied by a shift from a predominantly Th2 cytokine response to a distinct Th1 response.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Pathogen-free female C57BL/6J mice were obtained at 7–8 wks of age from Charles River Laboratory (Wilmington, MA). Mice were housed in the Animal Care Facility at the Ann Arbor Veterans Affairs Medical Center, which is fully accredited by the American Association for Accreditation of Laboratory Animal Care. This study complied with the National Institutes of Health "Guide for the Care and Use of Laboratory Animals" (Department of Health, Education, and Welfare Publication No. (National Insitutes of Health) 80-23). Mice were fed standard animal chow (Rodent Lab Chow 5001; Purina, St. Louis, MO) and chlorinated tap water ad libitum. Mice were used at 8–14 wks of age.
Monoclonal Abs
The following mAbs were purchased from PharMingen (San Diego,
CA): RM4-4 (anti-murine CD4; rat IgG2b), 53-6.72 (anti-murine
CD8; rat IgG2b), 1D3 (anti CD19), RM2-5 (anti CD2), 7D4
(anti-murine CD25, rat IgM), 145-2C-11 (hamster anti-murine
CD3), and H1.2F3 (anti-murine CD69, hamster IgG). Monoclonal Abs
were either directly FITC conjugated or biotinylated; in the latter
case staining was visualized using streptavidin-PE (PharMingen).
Isotype-matched irrelevant control Abs (107.3 (anti-TNP control
mouse IgG1, 
), anti-TNP hamster IgG, and rat IgM,
(PharMingen)) were tested simultaneously to exclude nonspecific
staining.
Induction of pulmonary immune response
SRBC (sheep 4151) (Colorado Serum, Denver, CO) were washed three
times in normal saline before use. Mice were Ag primed by i.p.
injection with 1 x 108 SRBC in 0.5 ml
normal saline. Beginning 2 wks later, mice were IT challenged with
5 x 108 SRBC in 50 µl normal saline as
previously described (7) either once (1IT group) or three
times with 1 wk between challenges (3IT group) (Fig. 1
). Two control experiments were
performed (Fig. 1). In control A, 4 wk elapsed between i.p. priming and
IT challenge. This experimental group was used to control for the
difference between the 1IT and 3IT groups in the time from initial
priming to final IT challenge. In control B, the first two of the 3IT
challenges used the same volume of normal saline rather than SRBC. This
experimental group was used to control for the repeated immunization
procedures to which the 3IT group was subjected. In a single additional
control experiment not depicted in Fig. 1, SRBC-primed mice were IT
challenged a single time with 50 µl saline containing India ink
(Pelikan, Hannover, Germany), and lungs were harvested 6 days later.
This group was used to analyze the effect of the immunization procedure
at the site of Ag deposition.
|
At various times from 0–14 d after the final IT Ag challenge, mice were deeply anesthetized with pentobarbital (80 mg/kg i.p.) and killed by exsanguination and induction of bilateral pneumothoraces. Lungs were then processed in one of three ways. First, to obtain lung inflammatory cells, some lungs were perfused via the right heart using normal saline, and then bronchoalveolar lavage (BAL) and total and differential cell counts were performed as previously described (3). Aliquots of these cells were stained with mAbs and analyzed on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA) as previously described (26), except that CellQuest software (Becton Dickinson) was used. Second, for histologic analysis some lungs were inflated using 1 ml 10% neutral-buffered formalin, and then the entire thoracic contents were dissected free and fixed by immersion in 10% formalin in PBS for 18–24 h. Parasagittal sections through these fixed lungs were then cut, embedded in paraffin, and sectioned at 5 µm thickness. The slides, each consisting of sections of both lungs from an individual mouse, were stained with hematoxylin and eosin and with Masson’s trichrome stains. Third, for samples to be analyzed for total lung cytokine mRNA or protein production, lungs that were perfused but not lavaged were carefully dissected to exclude any extrapleural lymphatic tissue. These lungs, separated from the mainstem bronchi at the medial pleural surface, were snap frozen in liquid nitrogen and stored at -70°C until processed as described below.
Apoptosis measurement
Apoptotic lymphocytes were measured using the Apoptosis Detection Kit (R&D Systems, Minneapolis, MN) according to the manufacturer’s instructions. This method uses flow cytometry to identify apoptotic cells as those that bind annexin V (27) and exclude propidium iodide.
Isolation of RNA
Lungs were homogenized in 2 ml of TRIzol reagent (Life Technologies, Grand Island, NY), and RNA was isolated as described in the TRIzol protocol. RNA was quantitated spectrophotometrically. The integrity of individual RNA samples was confirmed by electrophoresing aliquots on a 2% agarose gel containing 0.5 µg/ml ethidium bromide and observing 28S and 18S rRNA bands. RNA samples were stored at -70°C.
RT-PCR detection of cytokine mRNA
Isolated RNA was reverse transcribed to DNA as follows. To 20 µg RNA was added 24.4 µl of mix A (403 µl RNase inhibitor (Life Technologies; 10 U/ml) and 280 µl of random primers (Life Technologies, 3 µg/ml)), which was heated at 70°C for 2 min in a programmable thermocycler (Perkin-Elmer 9600, Norwalk, CT). The temperature was reduced to 4°C and 68.9 µl of mix B (812 µl of double distilled water, 300 µl of 0.1 M DTT, 75 µl of 20 mM each dNTP, 602 µl of 5x first-strand buffer, and 140 µl of 200 U/µl Moloney murine leukemia virus reverse transcriptase (all from Life Technologies)) was added. RNA was transcribed in this mixture for 1 h at 42°C, and then the reaction was stopped by a 5-min incubation at 95°C.
The DNA was subjected to PCR as follows. In a thin-walled PCR tube, 5 µl of sample was added to 20 µl of PCR buffer containing 5 nM of each dNTP, 50 nM MgCl2, 1.0 U of Taq DNA polymerase (all from Life Technologies), and 0.15 ng each of sense and anti-sense primers. Amplification was then performed in a thermocycler as follows: 5 min at 95°C, followed by up to 35 cycles of 15 s each at 95°C, 20 s at 58°C, 30 s at 72°C. After cycling, there was a DNA extension period of 6 min at 72°C. The amplified DNA was analyzed by electrophoresis on 1.5% agarose containing 0.5 µg/ml ethidium bromide.
The primer sequences used are defined in Table I. Primers were designed based upon
nucleotide sequences downloaded from the National Center for
Biotechnology Information data bank, using primer design software
(Primer 2; Scientific & Educational Software, State Line, PA). All
primers were prepared by the University of Michigan DNA Core Facility
(Ann Arbor, MI). PCR conditions and cycle number were defined for each
cytokine primer pair such that a linear relationship between input RNA
and final PCR product (defined as OD signal) was obtained. Positive and
negative controls were included in each assay to establish that only
cDNA PCR products were detected and that none of the reagents were
contaminated with cDNA or extraneous PCR products. Authenticity of
reaction products was verified by Southern analysis using a
chemiluminescent detection system (Amersham Life Science, Little
Chalfont, U.K.).
|
ELISA
Lungs frozen at -80°C were homogenized in 1 ml of PBS and
centrifuged at 1500 rpm. The supernatant was aliquoted and stored at
-80°C. These samples were analyzed for IFN-, IL-4, TNF-, IL-12
p40, and IL-10 using PharMingen kits according the manufacturer’s
instructions. OD readings of samples were converted to picograms per
milliliter using standard curves generated with varying concentrations
of recombinant cytokine supplied with the kit. The limit of detection
was 31.2 pg/ml for each assay.
Statistical analysis
Data were expressed as mean ± SEM. Statistical calculations were performed using Statview (Abacus Concepts, Berkeley, CA) on a Macintosh PowerPC G3 computer. Differences between the groups of mice in continuous ratio scale data at individual time points after final IT challenge were evaluated using the unpaired Student t test (28). Differences in cytokine levels between the groups of mice were evaluated using Mann-Whitney nonparametric unpaired analysis. Significant differences were defined as p < 0.05.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Lung lymphocyte numbers peaked at day 6 after single Ag challenge
and then progressively decreased, in agreement with previous data in
this model system. Compared with the 1IT group, lymphocyte numbers were
significantly decreased in the 3IT group on days 6 and 9 after final IT
challenge, but not during early inflammation (day 3) or on day 14, when
inflammation in both groups was largely resolved (Fig. 2). Histologic analysis showed a decrease
in the extent but no discernible change in the anatomic distribution of
inflammatory cell accumulation after 3IT (Fig. 3, A–D). Inflammatory cell
accumulation in both groups was chiefly associated with the
bronchovascular bundles and pulmonary veins, as previously reported
(5, 7). Examination of trichrome-stained sections did not
reveal any evidence of fibrosis. Histologic analysis of the lungs of
mice challenged solely with saline containing India ink to detect the
site of Ag deposition did not disclose inflammatory cell accumulation
(Fig. 3, E and F). Thus, kinetic analysis
indicated that, in this model system as in other models (14, 15, 16, 17, 18, 20, 21), repeated intrapulmonary Ag deposition led to a
diminution of the lung inflammatory cell response.
|
|
, 1 IT) or 4 wk (Fig. 1, Control A) before IT
SRBC injection, there were no significant differences in numbers of
total BAL inflammatory cells, macrophages, or lymphocytes (data not
shown). There were also no differences in BAL cell numbers or types
when comparing experiments with 1IT challenge and 3IT challenge where
the first two injections were saline (Fig. 1, Control B) (data not
shown). These results indicate that multiple surgeries or variations in
timing of i.p. injections were not the causes of differences between
1IT- and 3IT-challenged mice in lung lymphocyte numbers. Lung lymphocyte phenotypes change minimally after repeated Ag challenge
Flow cytometric analysis of lung lymphocyte phenotypes showed
significant differences only at day 9 after final IT challenge, when
3IT mice had a decreased percentage of CD19+
cells and increased percentage of CD8+ cells
(Fig. 4). Overall, there was a trend
toward an increasing fraction of CD4+ and toward
a decreasing fraction of CD19+ cells in the 3IT
group, both with time after challenge and relative to the 1IT group,
but these differences did not attain statistical significance. We and
others have previously reported that a large fraction of lymphocytes in
the lungs of immunized mice are negative for most subpopulation markers
(3, 29). In the current study, the percentage of such null
cells (defined as CD2+,
CD4-, CD8-, and
CD19- cells within light-scatter gates
characteristic of lymphocytes) did not differ between the two groups.
Thus, no systematic change in the distribution of lung lymphocyte
subsets between the two groups was consistently seen over the course of
the immune response.
|
). In all but two
of the comparisons, a greater percentage of both
CD4+ cells and CD8+ cells
were positive for these activation receptors in the 3IT group, although
the difference was statistically significant for only five of the 12
conditions tested.
|
To determine which cytokines may be involved in down-regulation of
the immune response in 3IT-challenged mice, we determined relative
levels of whole-lung cytokine mRNA by RT-PCR and of selected whole-lung
cytokine protein concentrations by ELISA. In the remainder of this
paper, significant differences between 1IT and 3IT mice are only
mentioned if results of 1IT as well as control A and control B mice are
similarly significantly different from those of 3IT mice. In the 1IT
groups, relative mRNA levels of the proinflammatory cytokine IL-1ß
was actually elevated at the time of initial IT challenge, perhaps
reflecting residual changes from previous i.p. priming (Fig. 5). IL-1ß levels were significantly
higher in the 1IT and control groups relative to 3IT at day 1. TNF-
mRNA levels were greater in 1IT and control groups than 3IT levels at
early time points but did not reach significance. Relative mRNA levels
of the antiinflammatory cytokine IL-10 peaked earlier in 3IT mice, at
day 1 compared with days 3–4 in 1IT and control (Fig. 5). Relative
mRNA levels of IL-6 were not significantly different between 3IT and
1IT and control groups at any time point.
|
was significantly increased in 1IT mice
compared with 3IT mice at days 1, 6, and 9 after final IT Ag challenge
(Fig. 6). The protein data for IL-10 also
indicated a stronger early response in 3IT mice although the levels
were significantly higher at later time points as well (Fig. 6). In
combination, these results indicate that the down-regulation of immune
response in 3IT-challenged mouse lungs is characterized by a decrease
in proinflammatory cytokines and an increase in IL-10.
|
To define the nature of the T cells involved in the reduction of
the immune response in 3IT mice, we examined expression of mRNA of
cytokines associated with Th1 (IFN-, IL-12 p40, IL-12 p35, and
IL-18) (Fig. 7) and Th2 (IL-4, IL-5, and
IL-13) responses (Fig. 8). In 1IT and
both groups of control mice, aside from an isolated relative mRNA
expression of IL-12 p35 at baseline, levels of both species of IL-12
and of IL-18 were minimal throughout the response to IT Ag challenge.
IFN- mRNA was increased only at day 1 in 1IT and control mice, and
then fell below the levels found in the 3IT group. Unlike this minimal
evidence of a Th1 response in the 1IT and control groups, there was a
striking predominance of relative mRNA expression of the Th2 cytokines
in these groups: IL-4 and IL-13 peaking at day 3 and IL-5 having high
relative levels on days 1–3 after IT challenge. By contrast, the 3IT
group showed markedly elevated expression of relative mRNA levels of
all four Th1 cytokines, and especially of IL-18. Conversely, there was
little expression of any of the three Th2 cytokines in the 3IT
group.
|
|
). Significantly
higher relative mRNA levels of IL-2 were seen at day 1 in 1IT and
control groups compared with 3IT mice. IL-15 is member of the
four-helix bundle cytokine family that mediates its function via the
ß- and -chains of the IL-2 receptor and that shares many of
IL-2’s T cell activation and chemoattractant properties
(30). Levels of IL-15 mRNA were increased early after Ag
challenge in all groups, with no significant differences between them
(Fig. 7).
Whole-lung protein levels of selected cytokines analyzed by ELISA
agreed with the patterns detected by mRNA analysis. The Th1 cytokines
IL-12 p40 and IFN- showed significantly elevated concentrations at
many time points in the 3IT mice relative to the 1IT group (Fig. 9). Whole-lung cytokine protein
concentrations of IL-4 agreed with the mRNA data, with a distinct peak
of activity on day 4 in the 1IT mice and lower concentrations in the
3IT group (Fig. 9). Taken together, these data demonstrate a
polarization of the response from a mixed response with features of a
Th2 response after one Ag challenge to a distinctly Th1 response after
repeated IT Ag challenge.
|
We next sought to examine several potential determinants of net
lung lymphocyte accumulation. The endothelial selectins E-selectin
(CD62E) and P-selectin (CD62P) are cell adhesion molecules that
initiate recruitment of type 1 T cells to sites of inflammation
(31). Expression of these molecules is induced by TNF-
and IL-1ß and is transcriptionally regulated. We have previously
found that expression of these selectins markedly increases after IT Ag
challenge in this model system (7) and that lymphoblasts
unable to bind to these molecules (due to genetic targeting of
fucosyltransferase VII, the rate-limiting enzyme in synthesis of
leukocyte ligands for the selectins) have significantly decreased
short-term recruitment to the lung (11). In the current
study, analysis of relative mRNA levels by RT-PCR showed slightly
decreased transcription of the genes for E-selectin and P-selectin in
the 3IT group compared with 1IT and control groups (Fig. 10).
|
). Thus, increased lymphocyte
apoptosis within the lungs also appears to contribute to the
physiologic down-regulation of lung inflammation during repeated IT Ag
challenge.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
, 7, 8, and 10, these changes occurred by day 3 after the third Ag exposure, while
the magnitude and duration of lung inflammation, as shown in Fig. 2, was still only mildly decreased below that seen with single Ag
challenge, whereas the major decrease in inflammation occurred at day
6. Hence, it is plausible that the cytokine changes are a cause, rather
than effect, of down-regulation. These novel findings provide a
mechanistic explanation for the diminished lung inflammation on
repeated intrapulmonary Ag exposure, which has been described in
numerous animal model systems (14, 15, 16, 17, 18, 20, 21). Murine model systems have become widely used in the study of pulmonary immunity, immunopathology, and host defense (32, 33, 34). For this purpose, SRBC Ag, used since the infancy of cellular immunology because it induces such a vigorous specific immune response in mice, has several advantages as a model Ag. SRBC are nonreplicating particles of a size that can be delivered reproducibly to the distal airspaces of the lungs. In primed mice, such challenge induces time- and Ag-dose-dependent lung inflammation (2, 9). By contrast, in the absence of Ag priming, challenge with even the large Ag doses used in the current study (near the maximum that can be administered without excessive numbers of mouse deaths during anesthesia) induce very little lung inflammation (35). Thus, although SRBC is not itself a clinically relevant allergen, it is likely the cytokine changes we found will be seen with other Ags that also do not directly activate the innate immune response or cause tissue damage. The lung inflammation seen in SRBC-challenged mice most closely resembles the human lung disease hypersensitivity pneumonitis, which is, however, a CD8-predominant condition resulting from chronic inhalation of organic Ags. The distribution and extent of peribronchovascular mononuclear cell infiltration in the SRBC model system is also similar to that seen in mice challenged with such Ags as OVA or Asperigillus (17, 36, 37), but features of asthma, such as epithelial cell damage or mucus hypersecretion, are not observed in the SRBC model in C57BL/6 mice.
The significant increase in lung IL-10 production seen in the 3IT group
suggests one potential unifying mechanism for down-regulation of lung
inflammation to repeated Ag challenge. IL-10 is a 178-aa glycoprotein
expressed as noncovalently linked homodimers that appears to act as a
naturally occurring antiinflammatory cytokine (38). IL-10
inhibits the release of IL-1ß, TNF-, macrophage inflammatory
protein-1, and monocyte chemoattractant protein-1 and prevents
Ag-specific Th1 cell proliferation and cytokine production both
directly and by reducing the Ag-presenting capacities of monocytes
(39, 40). However, to what degree defective production of
counterregulatory antiinflammatory cytokines such as IL-10 participates
in pathogenesis of lung disease is controversial. Initially identified
as a Th2 T cell product, IL-10 is now recognized to be produced by a
host of cell types, including alveolar macrophages and bronchial
epithelial cells (41, 42). The potential role of IL-10 to
suppress lung inflammation has been shown using knockout mice in murine
models of allergic bronchopulmonary aspergillosis and hypersensitivity
pneumonitis (37, 43), in Pseudomonas
aeruginosa-induced mouse lung damage during repeated challenge
(44), and in a rat model of lung response to quartz
(45). Because endogenous lung IL-10 levels increase early
during multiple IT SRBC challenge, our results suggest that IL-10 may
be playing a role in the down-regulation of immune response to repeated
particulate Ag challenge. Confirmation of that possibility awaits
further experimentation. However, recent studies indicate that IL-10
may not be required for down-regulation of mouse lung inflammation
associated with CpG DNA treatment of LPS-induced injury
(46), with blockade of the chemokine C10 in experimental
allergic bronchopulmonary aspergillosis (47), or during
resolution of replicative Legionella pneumophila infection
(48). Hence, the importance of IL-10 in down-regulation of
lung inflammation appears to vary with the experimental model
system.
The finding that IL-12 p40 mRNA and protein expression increased on
repeated Ag challenge is significant because IL-12 plays an important
role in both innate resistance and Ag-specific immunity to
intracellular bacterial, fungal, viral, and protozoan pathogens.
Moreover, a variety of protocols that down-regulate allergic
manifestations against soluble Ags, including infections with
Mycobacterium tuberculosis or adenovirus, administration of
unmethylated CpG oligodeoxynucleotides, and allergen-injection
immunotherapy, both up-regulate IL-12 and switch T cells toward a Th1
phenotype (49, 50, 51, 52). Endogenous production of IL-12 is
essential for the resistance of some murine strains to OVA-induced AHR
(53). Low-dose intranasal IL-12 decreased Ag-induced AHR
and lung eosinophilia in an OVA model of asthma in BALB/c mice
(54). Interestingly, Hofstra and colleagues found in
another OVA model in BALB/c mice that IL-12 plus IL-18, but not IL-12
alone, was required to significantly inhibit Ag-induced lung
eosinophilia, AHR, and elevated serum IgE (55). Therefore,
lung inflammation involving predominance of Th2 cytokines followed by
recovery associated with up-regulation of Th1 cytokines appears to be
well established in response to soluble Ags such as OVA. However, many
Ags of clinical significance are of a particulate nature, and with
these results are not as consistent. For example, human and animal
studies of hypersensitivity pneumonitis, a granulomatous inflammatory
lung disease caused by inhalation of particulate Ag (most commonly
thermophilic actinomycetes) indicate that Th1 cytokines predominate
during infection (56, 57). In contrast, particulate
Asperigillus fumigatus Ags elicited a Th2 response in BALB/c
mice (58, 59). Single IT SRBC challenge of primed A/J mice
induced AHR and lung eosinophilia in a CD4 T cell-dependent fashion
reminiscent of human asthma (4). In that model system,
repeated systemic administration of exogenous IL-12 at the time of a
second IT SRBC challenge abolished AHR and lung eosinophilia, increased
IFN-, and decreased IL-4 and IL-5 expression; these effects of IL-12
were only partially dependent on IFN- (8). The current
study extends these results by showing spontaneous production within
the lungs of IL-12, IL-18, and IFN- in response to repeated
particulate Ag challenge.
The dose of SRBC used in this study, although seemingly large, is in
the same range used by others measuring immune response to particulate
cellular Ag (4, 35, 60, 61). In contrast to soluble Ags,
generation of pulmonary immune responses to particulates typically
requires large Ag doses, presumably reflecting evolutionary pressure
for alveolar macrophages to eliminate particles without invoking lung
inflammation. Nevertheless, the immune response to particulates merits
investigation due to the large quantities of particulates to which even
normal individuals are repeatedly exposed focally through aspiration
(62) and more insidiously by inhalation (63).
With regard to the effect of dose on Th2/Th1 polarization, published
results are contradictory. Some studies have indicated that low-dose
soluble Ag preferentially supports IL-4 over IFN- production
(64, 65, 66, 67, 68, 69). A recent study using transgenic T cells bearing
a single TCR indicated that over the long term, high doses of
high-affinity peptides led selectively to IFN--secreting cells
whereas IL-4- and IL-5-secreting cells predominated with moderate doses
(70). In contrast, with intact organisms such as
Leishmania major, Trichuris muris, and
Schistosoma mansoni, a greater degree of Ag stimulation
induced a Th2 response, whereas single immunizations or low-level
infection favored Th1 cytokines (71, 72, 73). The cytokine
patterns seen in our 1IT and control groups are consistent with results
of a recent study that found that a high dose of SRBC (4 x
108 cells) given i.v. to naive CBA/J mice induces
either a mixed Th1/Th2 or a predominantly Th2 response, in contrast to
the Th1 response seen with lower doses (4 x
105 or 4 x 106 cells)
(61). Because Th1/Th2 polarization can also be influenced
by other variables including strength of TCR signal (65, 74), amount of costimulation (75), nature of
cytokines present (76), and T cell responsiveness to
particular cytokines (77), it is currently difficult to
predict accurately the effect of a given immunization protocol. The
results of the current study are important because they provide
additional information about the pulmonary immune response to
nonreplicating particulate Ag, and because they imply that route of Ag
administration should also be considered.
There are probably multiple causes for the observed decrease in lung lymphocyte accumulation in the 3IT group. Based on previous findings in this model system, decreased expression of endothelial selectins and increased lymphocyte apoptosis would both be anticipated to have major effects on steady-state lymphocyte accumulation and hence the severity and duration of lung inflammation. It is likely that lymphocyte retention within lung parenchyma is also decreased after repeated Ag challenge; however, we have not yet measured this parameter. We also did not measure local lymphocyte proliferation within the lungs, reasoning that it would be difficult to account for significant net changes between the groups based on further reduction of the already very low rate of proliferation previously seen in the 1IT protocol (12).
Several points about our results merit discussion in relationship to
previous studies using this experimental model system. Kaltreider and
colleagues demonstrated expression of cytokine proteins (IL-2, IL-4,
IL-6, and IFN-) as a function of time after a single IT SRBC
challenge (9). Because that study analyzed concentrated
BAL fluid, whereas ours analyzed total lung digests, the results are
not directly comparable. However, both studies found peak IL-4
production at 3–4 days after challenge. Our finding of decreased
lymphocyte and total leukocyte numbers in the 3IT group differ from
results of Denis and Bisson (35). In addition, they found
striking fibrosis in mice challenged three times, which was not
observed in our studies. There are several methodological differences
between our study and theirs, including control groups (they compared
3IT only to primed mice without IT challenge and to unprimed mice after
single IT challenge), interval between IT challenges (10-day rather
than 7-day intervals as is our studies), and method of cytokine
analysis (cytokines were analyzed in the supernatants of purified BAL T
cells stimulated in vitro with SRBC, whereas we measured protein levels
in unstimulated lung cell digests). Despite these methodological
differences, both the Denis and Bisson and our study found that protein
concentrations of IFN- increased on repeated Ag challenge,
consistent with evolution of a Th1 response. In agreement with our
findings, most other animal models of repeated stimulation using
exogenous Ag have found both decreased inflammation and distinct
difficulty in inducing fibrosis (14, 15, 16, 18, 20, 21).
In summary, this study demonstrates that, relative to single Ag challenge, repeated IT Ag challenge of primed mice is associated with significantly decreased lymphocyte accumulation and significant changes in total lung production of mRNA and proteins. These changes are down-regulation of inflammatory cytokines, up-regulation of the antiinflammatory cytokine IL-10, as well as striking Th1 polarization. These cytokine changes are associated with decreased transcription of the genes for the inducible endothelial selectins and by increased lung lymphocyte apoptosis. These results are important because similar mechanisms may act to minimize chronic lung inflammation in the majority of normal humans who do not develop progressive lung pathology when repeatedly exposed to inhaled or aspirated particulate environmental allergens and Ags.
|
Acknowledgments |
|---|
, and
IL-12 p35; Dr. Lloyd Stoolman for recombinant human IL-2; Angela
Preston, Kelly Warmington and Drs. James M. Beck, Paul
Christensen, Gary Huffnagle, and Bethany Moore for helpful suggestions;
Joyce O’Brien for secretarial support; Michael Hormuth and Carolyn
White for assistance with the photomicrographs; and Drs. Beck and Moore
for critiquing the manuscript. |
Footnotes |
|---|
2 Portions of these data were presented at the International Scientific Conference of the American Thoracic Society (San Diego, CA; April 27, 1999) and have been published in abstract form (1999 Am. J. Respir. Crit. Care Med. 159:A660).
3 Address correspondence and reprint requests to Dr. Jeffrey L. Curtis, Pulmonary and Critical Care Medicine Section (111G), Department of Veterans Affairs Medical Center, 2215 Fuller Road, Ann Arbor, MI 48105-2303.
4 Abbreviations used in this paper: IT, intratracheal; 1IT, group of mice which received a single Ag challenge; 3IT, group of mice which received three Ag challenges at weekly intervals; AHR, airways hyperresponsiveness; BAL, bronchoalveolar lavage.
Received for publication June 28, 1999. Accepted for publication February 3, 2000.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
4 integrin regulate independent pathways of T lymphocyte recruitment in pulmonary inflammation. J. Immunol. 161:4396.ß bearing cells infiltrating the lung during the immune response. Reg. Immunol. 4:25.[Medline]
, macrophage inflammatory protein- 2, interleukin-1ß, and interleukin-6 but not RANTES or transforming growth factor-ß 1 mRNA expression in acute lung inflammation. Am. J. Respir. Cell Mol. Biol. 10:148.[Abstract]
by T cells. Proc. Natl. Acad. Sci. USA 92:9510.This article has been cited by other articles:
|
|
 |
|
  J. J. Osterholzer, T. Ames, T. Polak, J. Sonstein, B. B. Moore, S. W. Chensue, G. B. Toews, and J. L. Curtis CCR2 and CCR6, but Not Endothelial Selectins, Mediate the Accumulation of Immature Dendritic Cells within the Lungs of Mice in Response to Particulate Antigen J. Immunol., July 15, 2005; 175(2): 874 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Ameredes, J. M. Sethi, H.-L. Liu, A. M. K. Choi, and W. J. Calhoun Enhanced nitric oxide production associated with airway hyporesponsiveness in the absence of IL-10 Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L868 - L873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Donnelly, S. M. O'Neill, M. Sekiya, G. Mulcahy, and J. P. Dalton Thioredoxin Peroxidase Secreted by Fasciola hepatica Induces the Alternative Activation of Macrophages Infect. Immun., January 1, 2005; 73(1): 166 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Morrison, C. B. Wilson, M. Ray, and P. H. Correll Macrophage-Stimulating Protein, the Ligand for the Stem Cell-Derived Tyrosine Kinase/RON Receptor Tyrosine Kinase, Inhibits IL-12 Production by Primary Peritoneal Macrophages Stimulated with IFN-{gamma} and Lipopolysaccharide J. Immunol., February 1, 2004; 172(3): 1825 - 1832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cheng, Y. Nefedova, L. Miele, B. A. Osborne, and D. Gabrilovich Notch signaling is necessary but not sufficient for differentiation of dendritic cells Blood, December 1, 2003; 102(12): 3980 - 3988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jussila, J. Pelkonen, V.-M. Kosma, J. Maki-Paakkanen, H. Komulainen, and M.-R. Hirvonen Systemic Immunoresponses in Mice after Repeated Exposure of Lungs to Spores of Streptomyces californicus Clin. Vaccine Immunol., January 1, 2003; 10(1): 30 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Curtis, J. Sonstein, R. A. Craig, J. C. Todt, R. N. Knibbs, T. Polak, D. C. Bullard, and L. M. Stoolman3 Subset-Specific Reductions in Lung Lymphocyte Accumulation Following Intratracheal Antigen Challenge in Endothelial Selectin-Deficient Mice J. Immunol., September 1, 2002; 169(5): 2570 - 2579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Morrison and P. H. Correll Activation of the Stem Cell-Derived Tyrosine Kinase/RON Receptor Tyrosine Kinase by Macrophage-Stimulating Protein Results in the Induction of Arginase Activity in Murine Peritoneal Macrophages J. Immunol., January 15, 2002; 168(2): 853 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Okada, T. Saito, Y. Masunaga, Y. Tsukada, S. Nakagawa, H. Mizuguchi, K. Mori, Y. Okada, T. Fujita, T. Hayakawa, et al. Efficient Antigen Gene Transduction Using Arg-Gly-Asp Fiber-Mutant Adenovirus Vectors Can Potentiate Antitumor Vaccine Efficacy and Maturation of Murine Dendritic Cells Cancer Res., November 1, 2001; 61(21): 7913 - 7919. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
; 3IT, 
. Absolute lymphocyte
numbers were determined as the product of total BAL cell count (by
hemocytometer) and lymphocyte percentage on differential cell count of
hematoxylin and eosin-stained preparations. Data represent mean ±
SEM of at least three mice assayed in two to five experiments per time
point; *, p < 0.05, unpaired Student
t test.
; control B, 
. Results are expressed as a
ratio of OD signal for a given cytokine to that for GAPDH, and fold
increases were calculated relative to normal mouse lung. Note the
difference in scale between individual cytokines. Each point represents
the mean and SEM of at least three mice. *, p <
0.05, unpaired nonparametric Mann-Whitney test comparing groups at the
same time point.
